RxDoctor Payments Data

Nicholas Robinson

Internal Medicine · Buffalo, NYNPI 1073925681

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $2,860,640 of the $2,861,957 with a category attached, or 100.0%. Pacira Pharmaceuticals Incorporated accounts for 100.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $2,394,127 and has fallen 100.0% since, to $1,164 in 2024. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,861,957in general payments, 2019–2025

Across 18 payments — averaging $158,998 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Pharmaceuticals Incorporated$2.9M
  • Prodigy Surgical Distribution, Inc.$1K
  • Pfizer$52
  • AbbVie$48
  • AstraZeneca$34
  • Boehringer Ingelheim$19

What the payments were for

  • Travel & lodging$9480%
  • Food & beverage$3690%
  • Ownership interest$2,860,640100%

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,861,957 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York

Other internal medicine in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →